Table 6.

Treatment outcomes in patients with stroke

Population	First-line AED	Response to first-line AED	Response to Lidocaine as a 2nd−/3rd-line AED	Response to Midazolam as a 2nd−/3rd-line AED	Response to other AEDs
45 newborns with stroke	45 (100%) phenobarbital	4 (5%) did not require further treatment	27 out of 32 (84%) patients treated with lidocaine responded (higher in full-term newborns and when used as a 2nd-line AED)	5 out of 32 (16%) patients treated with midazolam responded	1 patient responded to levetiracetam as a 3rd-line AED